Michel Linder

Prof. Michel Linder

orcid

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2011 in Journal of Food Engineering
Verified
Journal Article
Closed access
JBJennifer Burgain
Jennifer Burgain
CGclaire gaiani
claire gaiani
MLMichel Linder
Michel Linder
JSJ. Scher
J. Scher

Verified
Journal Article
Open access
PDF file
EPElodie Passeri
Elodie Passeri
Kamil ElkhouryKamil Elkhoury
Kamil Elkhoury
Margaretha MorsinkMargaretha Morsink
Margaretha Morsink
KBKerensa Broersen
Kerensa Broersen
MLMichel Linder
Michel Linder
Elmira Arab-TehranyElmira Arab-Tehrany
Elmira Arab-Tehrany
Alzheimer’s disease (AD) is the most frequent case of neurodegenerative disease and is becoming a major public health problem all over the world. Many therapeutic strategies have been explored for several decades; however, there is still no curative treatment, and the priority remains prevention. In this review, we present an update on the clinical and physiological phase of the AD spectrum, modifiable and non-modifiable risk factors for AD treatment with a focus on prevention strategies, then research models used in AD, followed by a discussion of treatment limitations. The prevention methods can significantly slow AD evolution and are currently the best strategy possible before the advanced stages of the disease. Indeed, current drug treatments have only symptomatic effects, and disease-modifying treatments are not yet available. Drug delivery to the central nervous system remains a complex process and represents a challenge for developing therapeutic and preventive strategies. Studies are underway to test new techniques to facilitate the bioavailability of molecules to the brain. After a deep study of the literature, we find the use of soft nanoparticles, in particular nanoliposomes and exosomes, as an innovative approach for preventive and therapeutic strategies in reducing the risk of AD and solving problems of brain bioavailability. Studies show the promising role of nanoliposomes and exosomes as smart drug delivery systems able to penetrate the blood–brain barrier and target brain tissues. Finally, the different drug administration techniques for neurological disorders are discussed. One of the promising therapeutic methods is the intranasal administration strategy which should be used for preclinical and clinical studies of neurodegenerative diseases.

16 July 2007 in European Journal of Lipid Science and Technology
Verified
Journal Article
Closed access
PDF file
VDVirginie Dubois
Virginie Dubois
SBSylvie Breton
Sylvie Breton
MLMichel Linder
Michel Linder
JFJacques Fanni
Jacques Fanni
MPMichel Parmentier
Michel Parmentier

1 October 2004 in Journal of Food Science
Verified
Journal Article
Closed access
PDF file
GGG.A. Gbogouri
G.A. Gbogouri
MLMichel Linder
Michel Linder
JFJ. Fanni
J. Fanni
MPM. Parmentier
M. Parmentier

1 June 2011 in Current Nanoscience
Verified
Journal Article
Closed access
BMB. Maherani
B. Maherani
EAE. Arab-Tehrany
E. Arab-Tehrany
M. R. MozafariM. R. Mozafari
M. R. Mozafari
CGclaire gaiani
claire gaiani
MLMichel Linder
Michel Linder
Today, liposomes are among the most applied technologies for the encapsulation and delivery of bioactive agents and many different compounds in biological, pharmaceutical, medical and nutritional research. In this review, classification of liposomal vesicles, methods of their preparation and encapsulation, as well as their applications in food, cosmetics and pharmaceutical industries are reviewed. In addition, the main analytical approaches used to study liposome characteristics such as size, transition temperature, surface charge, fluidity, lamellarity, stability and encapsulation efficiency are presented. In the final part of the article, mechanisms of liposome targeting are discussed.

1 May 2012 in Trends in Food Science & Technology
Verified
Journal Article
Closed access
EAElmira Arab-Tehrany
Elmira Arab-Tehrany
MJMuriel Jacquot
Muriel Jacquot
CGclaire gaiani
claire gaiani
MIMuhammad Imran
Muhammad Imran
SDStephane Desobry
Stephane Desobry
MLMichel Linder
Michel Linder